A Research titled: – STUDIES ON GENETICS is currently been conducted by:
Dr. Bruce Carleton Chair, Division of Translational Therapeutics Faculty of Medicine University of British Columbia
As per Dr. Carleton, the central theme of his research program, Pharmaceutical Outcomes and Policy Innovations (POPi), is the study of drug therapy with the goal of improving human health and quality of life.
He is interested in developing models for evaluating drug effectiveness, medication use models designed to improve patient health, and effective surveillance systems to improve the safe use of medication. He also has an interest in the clinical management of patients who experience serious adverse drug reactions.
You can learn more about Dr. Carleton’s research program by emailing him at the email address listed below.
FOR DETAILS ABOUT THIS RESEARCH PROJECT:
Please email: bcarleton@popi.ubc.ca
Survivors and family members of Stevens-Johnson Syndrome & Toxic Epidermal Necrolysis are encouraged to get involved.